Crocs: Q3 Earnings Snapshot

Published Fri, 01 Nov 2024 03:39:36 GMT

Crocs: Q3 Earnings Snapshot BROOMFIELD, Colo. (AP) — BROOMFIELD, Colo. (AP) — Crocs Inc. (CROX) on Thursday reported third-quarter profit of $177 million.On a per-share basis, the Broomfield, Colorado-based company said it had profit of $2.87. Earnings, adjusted for non-recurring costs, were $3.25 per share.The results topped Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $3.09 per share.The footwear company posted revenue of $1.05 billion in the period, also exceeding Street forecasts. Seven analysts surveyed by Zacks expected $1.03 billion.Crocs expects full-year earnings in the range of $11.55 to $11.85 per share._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CROX at https://www.zacks.com/ap/CROXSource

Karyopharm Therapeutics: Q3 Earnings Snapshot

Published Fri, 01 Nov 2024 03:39:36 GMT

Karyopharm Therapeutics: Q3 Earnings Snapshot NEWTON, Mass. (AP) — NEWTON, Mass. (AP) — Karyopharm Therapeutics Inc. (KPTI) on Thursday reported a loss of $34.5 million in its third quarter.On a per-share basis, the Newton, Massachusetts-based company said it had a loss of 30 cents.The results did not meet Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 28 cents per share.The pharmaceutical company posted revenue of $36 million in the period, also falling short of Street forecasts. Seven analysts surveyed by Zacks expected $37.3 million._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KPTI at https://www.zacks.com/ap/KPTISource

Thermon Group: Fiscal Q2 Earnings Snapshot

Published Fri, 01 Nov 2024 03:39:36 GMT

Thermon Group: Fiscal Q2 Earnings Snapshot AUSTIN, Texas (AP) — AUSTIN, Texas (AP) — Thermon Group Holdings Inc. (THR) on Thursday reported profit of $14.7 million in its fiscal second quarter.On a per-share basis, the Austin, Texas-based company said it had profit of 43 cents. Earnings, adjusted for non-recurring costs, were 49 cents per share.The maker of heat tracing products posted revenue of $123.7 million in the period.Thermon Group expects full-year earnings in the range of $1.84 to $1.94 per share, with revenue in the range of $478 million to $498 million._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on THR at https://www.zacks.com/ap/THRSource

ICE: Q3 Earnings Snapshot

Published Fri, 01 Nov 2024 03:39:36 GMT

ICE: Q3 Earnings Snapshot ATLANTA (AP) — ATLANTA (AP) — IntercontinentalExchange Group Inc. (ICE) on Thursday reported third-quarter profit of $541 million.The Atlanta-based company said it had profit of 96 cents per share. Earnings, adjusted for one-time gains and costs, were $1.46 per share.The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.40 per share.The owner of the New York Stock Exchange and other stock markets posted revenue of $2.43 billion in the period. Its adjusted revenue was $2 billion, which did not meet Street forecasts. Six analysts surveyed by Zacks expected $2.01 billion._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ICE at https://www.zacks.com/ap/ICESource

Distribution Solutions: Q3 Earnings Snapshot

Published Fri, 01 Nov 2024 03:39:36 GMT

Distribution Solutions: Q3 Earnings Snapshot CHICAGO (AP) — CHICAGO (AP) — Distribution Solutions Group, Inc. (DSGR) on Thursday reported a loss of $1.6 million in its third quarter.The Chicago-based company said it had a loss of 3 cents per share. Earnings, adjusted for non-recurring costs, came to 17 cents per share.The industrial products and tools maker posted revenue of $438.9 million in the period._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DSGR at https://www.zacks.com/ap/DSGRSource

Gibraltar Industries: Q3 Earnings Snapshot

Published Fri, 01 Nov 2024 03:39:36 GMT

Gibraltar Industries: Q3 Earnings Snapshot BUFFALO, N.Y. (AP) — BUFFALO, N.Y. (AP) — Gibraltar Industries Inc. (ROCK) on Thursday reported profit of $39.3 million in its third quarter.On a per-share basis, the Buffalo, New York-based company said it had net income of $1.28. Earnings, adjusted for one-time gains and costs, came to $1.38 per share.The building-products company posted revenue of $390.7 million in the period.Gibraltar Industries expects full-year earnings in the range of $4.05 to $4.15 per share, with revenue in the range of $1.37 billion to $1.4 billion._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ROCK at https://www.zacks.com/ap/ROCKSource

Vital Farms: Q3 Earnings Snapshot

Published Fri, 01 Nov 2024 03:39:36 GMT

Vital Farms: Q3 Earnings Snapshot AUSTIN, Texas (AP) — AUSTIN, Texas (AP) — Vital Farms, Inc. (VITL) on Thursday reported third-quarter earnings of $4.5 million.On a per-share basis, the Austin, Texas-based company said it had profit of 10 cents.The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 4 cents per share.The company posted revenue of $110.4 million in the period, which met Street forecasts.Vital Farms expects full-year revenue of $465 million._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VITL at https://www.zacks.com/ap/VITLSource

Cummins: Q3 Earnings Snapshot

Published Fri, 01 Nov 2024 03:39:36 GMT

Cummins: Q3 Earnings Snapshot COLUMBUS, Ind. (AP) — COLUMBUS, Ind. (AP) — Cummins Inc. (CMI) on Thursday reported third-quarter profit of $656 million.The Columbus, Indiana-based company said it had net income of $4.59 per share. Earnings, adjusted for non-recurring costs, were $4.73 per share.The results topped Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $4.63 per share.The engine maker posted revenue of $8.43 billion in the period, also surpassing Street forecasts. Six analysts surveyed by Zacks expected $8.14 billion._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CMI at https://www.zacks.com/ap/CMISource

Laureate Education: Q3 Earnings Snapshot

Published Fri, 01 Nov 2024 03:39:36 GMT

Laureate Education: Q3 Earnings Snapshot MIAMI (AP) — MIAMI (AP) — Laureate Education Inc. (LAUR) on Thursday reported net income of $36.2 million in its third quarter.On a per-share basis, the Miami-based company said it had profit of 23 cents.The for-profit higher education purveyor posted revenue of $361.5 million in the period.Laureate Education expects full-year revenue in the range of $1.46 billion to $1.47 billion._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LAUR at https://www.zacks.com/ap/LAURSource

BridgeBio Pharma: Q3 Earnings Snapshot

Published Fri, 01 Nov 2024 03:39:36 GMT

BridgeBio Pharma: Q3 Earnings Snapshot PALO ALTO, Calif. (AP) — PALO ALTO, Calif. (AP) — BridgeBio Pharma Inc. (BBIO) on Thursday reported a loss of $177 million in its third quarter.The Palo Alto, California-based company said it had a loss of $1.08 per share.The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 86 cents per share.The rare disease drug developer posted revenue of $4.1 million in the period, also missing Street forecasts. Four analysts surveyed by Zacks expected $5.3 million.BridgeBio Pharma shares have more than tripled since the beginning of the year. The stock has more than doubled in the last 12 months._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BBIO at https://www.zacks.com/ap/BBIOSource